3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
5
Breast Neoplasms
5
Stomach Neoplasms
3
Neoplasms
3
Malnutrition
3
Lung Neoplasms
3
Diarrhea
3
Mucositis
2
Enteritis
2
Chalazion
2
Carcinoma, Hepatocellular
2
Thyroid Neoplasms
1
Squamous Intraepithelial Lesions
1
Smoldering Multiple Myeloma
1
Psychological Well-Being
1
Polycystic Ovary Syndrome
1
Periampullary Carcinoma Nos
1
Pelvic Neoplasms
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Neoplasms, Second Primary
1
Muscle Invasive Bladder Cancer (MIBC)
1
Multiple Myeloma
1
Motor Activity
1
Monoclonal Gammopathy of Undetermined Significance
1
Liver Cirrhosis
1
Limited Stage Small Cell Lung Cancer
1
Laryngeal Neoplasms
1
Inflammation
1
Infections
1
Interventions
Metformin
139
Clomiphene
44
Letrozole
36
Inositol
28
Folic Acid
17
Exercise
17
Progesterone
16
Ethinyl Estradiol
13
Caloric Restriction
13
drospirenone and ethinyl estradiol combination
12
Estradiol
12
Contraceptives, Oral
11
cetrorelix
10
Pioglitazone
10
High-Intensity Interval Training
10
Chorionic Gonadotropin
10
Triptorelin Pamoate
9
Tablets
9
Spironolactone
8
Diet
8
Cholecalciferol
8
Vitamin D
7
Thioctic Acid
7
Surveys and Questionnaires
7
Menotropins
7
Liraglutide
7
Gonadotropins
7
Acupuncture Therapy
7
drospirenone
6
Ovidrel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Polycystic Ovary Syndrome
×
Probiotics
×
Clear all
NCT04593459
2024-03-22
ProPCO-RCT
Medical University of Graz
Phase 4
Completed
112 enrolled